Is MVMDF or JNJ a better dividend investment in 2026?

MVMDF currently yields 3454.23% with a 5% 5-year dividend growth rate. JNJ yields 2.14% with 5.8% growth. The better choice depends on your goal: MVMDF offers higher current income.

What is the dividend yield difference between MVMDF and JNJ?

MVMDF has a forward dividend yield of 3454.23% ($2.00/share annually). JNJ yields 2.14% ($5.20/share annually). The yield gap is 3452.09 percentage points.

Home › Compare › MVMDF vs JNJ

MVMDF vs JNJ: Dividend Comparison 2026

MVMDF yields 3454.23% · JNJ yields 2.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MVMDF wins by $1750296031922.79M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MVMDF

● Live price

3454.23%

Share price

$0.06

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1750296031922.82M

Annual income

$1,655,989,058,387,000,000.00

Full MVMDF calculator →

JNJ

Johnson & Johnson

● Live price

2.14%

Share price

$242.49

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.5K

Annual income

$4,749.88

Full JNJ calculator →

Portfolio growth — MVMDF vs JNJ

📍 MVMDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MVMDF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MVMDF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MVMDF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MVMDF

Annual income on $10K today (after 15% tax)

$293,609.67/yr

After 10yr DRIP, annual income (after tax)

$1,407,590,699,628,950,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$182.28/yr

After 10yr DRIP, annual income (after tax)

$4,037.40/yr

At 15% tax rate, MVMDF beats the other by $1,407,590,699,628,946,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MVMDF + JNJ for your $10,000?

MVMDF: 50%JNJ: 50%

100% JNJ50/50100% MVMDF

Portfolio after 10yr

$875148015961.43M

Annual income

$827,994,529,193,502,500.00/yr

Blended yield

94.61%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MVMDF

No analyst data

Altman Z

-34.2

Piotroski

2/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-5.7% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MVMDF buys

JNJ buys

No recent congressional trades found for MVMDF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMVMDFJNJ

Forward yield	3454.23% ✓	2.14%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$1750296031922.82M ✓	$30.5K
Annual income after 10y	$1,655,989,058,387,000,000.00 ✓	$4,749.88
Total dividends collected	$1743821578214.05M ✓	$15.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: MVMDF vs JNJ ($10,000, DRIP)

Year	MVMDF Portfolio	MVMDF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$356,123	$345,423.14	$10,594	$274.49	+$345.5K → MVMDF
2	$11,877,610	$11,496,558.47	$11,294	$360.69	+$11.87M → MVMDF
3	$371,063,612	$358,354,569.07	$12,133	$476.91	+$371.05M → MVMDF
4	$10,859,851,145	$10,462,813,080.41	$13,156	$635.42	+$10859.84M → MVMDF
5	$297,800,643,222	$286,180,602,496.39	$14,432	$854.61	+$297800.63M → MVMDF
6	$7,652,938,324,120	$7,334,291,635,872.50	$16,056	$1,162.76	+$7652938.31M → MVMDF
7	$184,336,344,926,485	$176,147,700,919,676.62	$18,175	$1,604.53	+$184336344.91M → MVMDF
8	$4,162,539,067,755,878	$3,965,299,178,684,539.00	$21,009	$2,252.68	+$4162539067.73M → MVMDF
9	$88,137,358,444,695,260	$83,683,441,642,196,480.00	$24,911	$3,229.73	+$88137358444.67M → MVMDF
10	$1,750,296,031,922,824,200	$1,655,989,058,387,000,000.00	$30,458	$4,749.88	+$1750296031922.79M → MVMDF

MVMDF vs JNJ: Complete Analysis 2026

MVMDF — Stock

Mountain Valley MD Holdings Inc., through its subsidiary, Mountain Valley MD Inc., operates as a health and wellness company. The company engages in the implementation and licensing of its technologies to pharmaceutical, vaccine, and nutraceutical third parties. It offers Quicksome oral drug formulation and delivery technologies; Quicksol solubility formulation technology; and dose sparing adjuvant. In addition, the company is developing IM032 for the treatment of male beagle dogs for comparing intramuscular and subcutaneous dosing. Mountain Valley MD Holdings Inc. is headquartered in Concord, Canada.

Full MVMDF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this MVMDF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MVMDF vs SCHD MVMDF vs JEPI MVMDF vs O MVMDF vs KO MVMDF vs MAIN MVMDF vs ABBV MVMDF vs MRK MVMDF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.